These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 17822806)
1. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11). Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. Batuwangala M; Camarda V; McDonald J; Marzola E; Lambert DG; Ng LL; Calo' G; Regoli D; Trapella C; Guerrini R; Salvadori S Peptides; 2009 Jun; 30(6):1130-6. PubMed ID: 19463746 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study on human urotensin II. Guerrini R; Camarda V; Marzola E; Arduin M; Calo G; Spagnol M; Rizzi A; Salvadori S; Regoli D J Pept Sci; 2005 Feb; 11(2):85-90. PubMed ID: 15635628 [TBL] [Abstract][Full Text] [Related]
4. A new ligand for the urotensin II receptor. Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist. Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276 [TBL] [Abstract][Full Text] [Related]
7. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide. Grieco P; Carotenuto A; Campiglia P; Gomez-Monterrey I; Auriemma L; Sala M; Marcozzi C; d'Emmanuele di Villa Bianca R; Brancaccio D; Rovero P; Santicioli P; Meini S; Maggi CA; Novellino E J Med Chem; 2009 Jul; 52(13):3927-40. PubMed ID: 19432421 [TBL] [Abstract][Full Text] [Related]
8. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites. Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254 [TBL] [Abstract][Full Text] [Related]
9. Identification of new agonists of urotensin-II from a cyclic peptide library. Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y Bioorg Med Chem; 2009 Sep; 17(18):6742-7. PubMed ID: 19695883 [TBL] [Abstract][Full Text] [Related]
10. Urotensin-II receptor ligands. From agonist to antagonist activity. Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788 [TBL] [Abstract][Full Text] [Related]
11. Ligand-supported purification of the urotensin-II receptor. Du AT; Onan D; Dinh DT; Lew MJ; Ziogas J; Aguilar MI; Pattenden LK; Thomas WG Mol Pharmacol; 2010 Oct; 78(4):639-47. PubMed ID: 20647393 [TBL] [Abstract][Full Text] [Related]
12. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems. Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525 [TBL] [Abstract][Full Text] [Related]
13. Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships. Lescot E; Bureau R; Rault S Peptides; 2008 May; 29(5):680-90. PubMed ID: 18022732 [TBL] [Abstract][Full Text] [Related]
14. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. Boucard AA; Sauvé SS; Guillemette G; Escher E; Leduc R Biochem J; 2003 Mar; 370(Pt 3):829-38. PubMed ID: 12495432 [TBL] [Abstract][Full Text] [Related]
15. Unraveling the active conformation of urotensin II. Carotenuto A; Grieco P; Campiglia P; Novellino E; Rovero P J Med Chem; 2004 Mar; 47(7):1652-61. PubMed ID: 15027856 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography. Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260 [TBL] [Abstract][Full Text] [Related]
18. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay. Brkovic A; Hattenberger A; Kostenis E; Klabunde T; Flohr S; Kurz M; Bourgault S; Fournier A J Pharmacol Exp Ther; 2003 Sep; 306(3):1200-9. PubMed ID: 12807997 [TBL] [Abstract][Full Text] [Related]
19. Urotensin-II receptor peptide agonists. Carotenuto A; Grieco P; Novellino E; Rovero P Med Res Rev; 2004 Sep; 24(5):577-88. PubMed ID: 15224381 [TBL] [Abstract][Full Text] [Related]